2023年6月26日

|雅培,卡地納健康、美敦力全球愛德華生命科學公司介入心髒病學設備估計市場需求增加,從2022年到2032年的複合年增長率在8.4%從164億美元到369億美元。日益增長的老年人口,增加冠狀動脈疾病的發病率,以及開發新的和複雜的產品,推動市場擴張。得到一個PDF樣本與最新市場Insights@ https://www.futuremarketinsights.com/reports/sample/rep - gb - 14684替代藥物的可用性,以及產品的失敗和回憶說,5月,然而,阻礙整個預測期內市場增長。此外,由於封鎖和社會疏遠,醫院已經下降,導致減少介入心髒病學商品的銷售。在最近幾個季度,介入性心髒設備行業的領先企業,其中包括波士頓科技公司,美敦力公司,雅培,經曆了收入減少。盡管如此,高頻率的心髒和血液循環疾病,尤其在英國,預計提高對介入性心髒病學設備的需求。糖尿病和高血壓也介入心髒病學設備需求的風險因素,這些疾病患病率上升預期的主要市場,成為全球人口老齡化。因為他們的巨大高級人群和糖尿病發病率高,新興經濟體,如印度,中國,巴西存在相當大的潛在的商業機會。由於冠狀動脈疾病的高發和早期檢測的意識增加,血管造影導管有最大的市場份額介入心髒病學設備。因為的原因如糖尿病患病率不斷上升,人口老齡化,還款的可用性,和北美重要的公司的存在,現在占主導地位的產業。 Get In Touch With Our Team For Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-14684 KEY TAKEAWAYS: Angioplasty Stents from the marketing attribution software market are expected to grow at the fastest CAGR of 8% through 2032. North America is expected to develop significantly in the region sector of the marketing attribution software market, with a CAGR of 7.9% through 2032. The marketing attribution software market in the United States is estimated to reach $12.9 billion by 2032, increasing at an 8.2% CAGR through 2032. With a CAGR of 7.8% through 2032, China is expected to achieve a market size of US$ 2.7 billion in marketing attribution software by 2032. The marketing attribution software market in the United Kingdom is expected to be worth US$ 1.5 billion by 2032, growing at a 7.5% CAGR through 2032. Japan is expected to have a market size for marketing attribution software of US$ 2.1 Billion by 2032, with a CAGR of 6.7% through 2032. By 2032, South Korea is expected to reach a market size of US$ 1.3 Billion in marketing attribution software, with a CAGR of 6.2% through 2032. COMPETITIVE LANDSCAPE: Medtronic (US), Boston Scientific Corporation (US), Abbott (US), Edward Lifesciences Corporation (US), Cardinal Health (US), iVascular (Spain), Becton, Dickinson, and Company (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KGaA are prominent Interventional Cardiology Devices market players (Germany). Expand Operations in the Future – To Get Requisite Details, Ask for a Custom Report@ https://www.futuremarketinsights.com/customization-available/rep-gb-14684 Key Segments